Oura, known for its smart health-tracking ring, has confidentially filed for an initial public offering in the US, signaling renewed strength in the IPO market as public investors show growing interest in wellness technology.
- Oura valued at $11 billion in recent funding round
- More than 5.5 million rings sold worldwide
- IPO filing follows rebound in US public markets
What happened
Oura, the Finnish company behind the Oura Ring health tracker, has submitted a confidential filing to go public on the US stock market. This marks a significant step for the firm, which has grown rapidly and expanded its retail presence globally, now reaching over 4,600 stores. The company’s wearable focuses on tracking sleep, activity, and other wellness metrics without being classified as a medical device.
The confidential filing process allows Oura to prepare its IPO away from immediate market scrutiny, a strategic move common among firms gearing up for public offerings. Notably, this announcement comes on the heels of SpaceX’s own IPO filing, which has injected fresh momentum into the US public offering landscape.
Why it matters
Oura’s IPO filing arrives during a revival in the US public markets after a period of subdued activity earlier in the year, underscoring renewed investor appetite for innovative tech and wellness companies. Oura’s valuation of around $11 billion reflects both its commercial success and the increasing value placed on health technology solutions that enable personalized wellness management.
The company’s rapid revenue growth—quadrupling over two fiscal years—and reinvestment of profits into its business highlight its commitment to expanding its market reach and product capabilities. Its strategic partnership as the official wearable device provider for Team USA and the LA28 Olympic Games also reinforces its position in elite sports and wellness sectors.
What to watch next
Stakeholders will be closely monitoring Oura’s IPO details, including the final share offer size and pricing once disclosed. Market conditions, investor sentiment toward wearable health tech, and competitive dynamics in the space will all influence the success of the public listing.
Additionally, Oura’s ability to sustain growth and expand its technology platform post-IPO, as well as leverage high-profile partnerships, will be key indicators of its long-term potential in a market increasingly focused on digital health and personalized wellness.